A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity
Open Access
- 21 August 2006
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 26 (8), 1178-1187
- https://doi.org/10.1038/sj.onc.1209899
Abstract
Anaplastic thyroid cancer (ATC) is one of the most lethal of all human tumors, but cytogenetic information concerning ATC is extremely limited. Using our in-house array-based comparative genomic hybridization and 14 ATC cell lines with further fluorescence in situ hybridization analysis, we demonstrated amplification of the DUSP26 gene, known by another report as MAP kinase phosphatase-8. DUSP26 was overexpressed in ATC cell lines and primary ATC tumor samples. When overexpressed, either exogenously or endogenously, DUSP26 promoted growth of the ATC cells. DUSP26 encodes a protein containing a dual-specificity phosphatase domain that can dephosphorylate itself. DUSP26 effectively dephosphorylates p38 and has a little effect on extracellular signal-regulated kinase in ATC cells. DUSP26 protein formed a physical complex with p38, and promoted survival of ATC cells by inhibiting p38-mediated apoptosis. Our findings suggest that DUSP26 may act as an oncogene in ATC, and might be a useful diagnostic marker and therapeutic target of this disease.Keywords
This publication has 42 references indexed in Scilit:
- Association and Regulation of Heat Shock Transcription Factor 4b with both Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Dual-Specificity Tyrosine Phosphatase DUSP26Molecular and Cellular Biology, 2006
- ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylationOncogene, 2005
- A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenesOncogene, 2005
- MKP-8, a novel MAPK phosphatase that inhibits p38 kinaseBiochemical and Biophysical Research Communications, 2005
- Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancersHuman Molecular Genetics, 2005
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12–13, reduces BCR-ABL-induced transformationOncogene, 2003
- Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapyHead & Neck, 2003
- A Novel MAPK Phosphatase MKP-7 Acts Preferentially on JNK/SAPK and p38α and β MAPKsJournal of Biological Chemistry, 2001
- The Molecular Basis of Oncogenes and Tumor Suppressor GenesAnnals of the New York Academy of Sciences, 1995